Hutch News
Results per Page:
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight
Inaugural 'Oncology Summit' addresses academic-industry partnerships
Fred Hutch, Merck co-host inaugural ‘Oncology Summit’ to capture non-profit and for-profit outlooks on cancer care
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements
Why cancer research needs business development – now more than ever
Meet Fred Hutch’s Dr. Niki Robinson, the woman who’s helping make it happen
Study may lead to development of new diagnostic tools for ovarian cancer
Research co-led by Harlan Robins and Adaptive Biotechnologies reveals an even distribution of immune fighter T cells in ovarian tumors
Detecting earliest signs of cancer relapse: Study finds high-throughput sequencing outpaces flow cytometry
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method